End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-05 pm EDT
|
5-day change
|
1st Jan Change
|
4.7
CNY
|
+3.75%
|
|
+8.80%
|
-12.96%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,904
|
3,568
|
3,900
|
4,179
|
3,615
|
4,017
|
Enterprise Value (EV)
1 |
2,625
|
3,420
|
3,601
|
4,283
|
4,042
|
4,422
|
P/E ratio
|
20.3
x
|
16.3
x
|
16.7
x
|
16.8
x
|
97.2
x
|
90
x
|
Yield
|
6.91%
|
0.85%
|
2.07%
|
-
|
-
|
1.24%
|
Capitalization / Revenue
|
0.78
x
|
0.93
x
|
0.87
x
|
0.8
x
|
0.74
x
|
0.71
x
|
EV / Revenue
|
0.7
x
|
0.89
x
|
0.81
x
|
0.82
x
|
0.83
x
|
0.78
x
|
EV / EBITDA
|
13.8
x
|
15.1
x
|
12.4
x
|
13
x
|
23.9
x
|
37.4
x
|
EV / FCF
|
-11.6
x
|
-60.1
x
|
81.6
x
|
-13.3
x
|
-26.7
x
|
-139
x
|
FCF Yield
|
-8.63%
|
-1.66%
|
1.23%
|
-7.52%
|
-3.74%
|
-0.72%
|
Price to Book
|
0.98
x
|
1.19
x
|
1.22
x
|
1.25
x
|
1.08
x
|
1.18
x
|
Nbr of stocks (in thousands)
|
754,329
|
754,329
|
754,329
|
754,329
|
743,856
|
743,856
|
Reference price
2 |
3.850
|
4.730
|
5.170
|
5.540
|
4.860
|
5.400
|
Announcement Date
|
4/2/19
|
4/28/20
|
4/29/21
|
4/12/22
|
4/28/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,729
|
3,851
|
4,468
|
5,193
|
4,882
|
5,694
|
EBITDA
1 |
189.9
|
226.5
|
290.1
|
328.2
|
169
|
118.4
|
EBIT
1 |
131
|
164.9
|
226.4
|
258.3
|
91.1
|
37.28
|
Operating Margin
|
3.51%
|
4.28%
|
5.07%
|
4.97%
|
1.87%
|
0.65%
|
Earnings before Tax (EBT)
1 |
184.7
|
258.5
|
285.3
|
301.8
|
51.23
|
39.65
|
Net income
1 |
144.8
|
218.5
|
232.7
|
248.9
|
40.96
|
44.07
|
Net margin
|
3.88%
|
5.67%
|
5.21%
|
4.79%
|
0.84%
|
0.77%
|
EPS
2 |
0.1900
|
0.2900
|
0.3100
|
0.3300
|
0.0500
|
0.0600
|
Free Cash Flow
1 |
-226.5
|
-56.87
|
44.12
|
-321.9
|
-151.3
|
-31.78
|
FCF margin
|
-6.07%
|
-1.48%
|
0.99%
|
-6.2%
|
-3.1%
|
-0.56%
|
FCF Conversion (EBITDA)
|
-
|
-
|
15.21%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
18.96%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2660
|
0.0400
|
0.1070
|
-
|
-
|
0.0670
|
Announcement Date
|
4/2/19
|
4/28/20
|
4/29/21
|
4/12/22
|
4/28/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
104
|
426
|
405
|
Net Cash position
1 |
279
|
148
|
299
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.3175
x
|
2.524
x
|
3.426
x
|
Free Cash Flow
1 |
-226
|
-56.9
|
44.1
|
-322
|
-151
|
-31.8
|
ROE (net income / shareholders' equity)
|
4.98%
|
7.29%
|
7.45%
|
7.56%
|
1.25%
|
1.21%
|
ROA (Net income/ Total Assets)
|
2.24%
|
2.64%
|
3.44%
|
3.72%
|
1.19%
|
0.45%
|
Assets
1 |
6,463
|
8,286
|
6,760
|
6,697
|
3,447
|
9,773
|
Book Value Per Share
2 |
3.940
|
3.960
|
4.220
|
4.440
|
4.510
|
4.590
|
Cash Flow per Share
2 |
0.5100
|
0.7600
|
0.8700
|
0.5000
|
0.6500
|
0.7800
|
Capex
1 |
85.8
|
105
|
155
|
159
|
174
|
162
|
Capex / Sales
|
2.3%
|
2.73%
|
3.47%
|
3.06%
|
3.57%
|
2.85%
|
Announcement Date
|
4/2/19
|
4/28/20
|
4/29/21
|
4/12/22
|
4/28/23
|
4/17/24
|
|
1st Jan change
|
Capi.
|
---|
| -12.96% | 464M | | +15.43% | 64.97B | | -1.42% | 47.76B | | +14.49% | 40.72B | | +20.84% | 26.88B | | +9.40% | 19.29B | | +2.39% | 17.53B | | -21.87% | 16.03B | | +1.52% | 15.17B | | -9.48% | 15.06B |
Other Specialty Chemicals
|